oral calcium and magnesium on the reduction of pms
Phase 3
- Conditions
- N94.3Premenstrual syndrome.Premenstrual tension syndrome
- Registration Number
- IRCT20160709028844N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 195
Inclusion Criteria
Female students of Shahrekord University of Medical Sciences with definite diagnosis of premenstrual syndrome
Not using other treatment methods
Willingness to participate in the study
Not suffering from known physical and mental diseases
single
Calendar age 18 to 27 years
Regular menstrual cycle of 21 to 35 days
Menstruation duration 3-7 days during the last six months
In terms of the severity of PMS symptoms, they were matched according to the DSM-V score
Exclusion Criteria
Reluctance to participate in the study
Use of other treatment methods
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Premenstrual syndrome. Timepoint: The beginning of the study and 1, 2 and 3 months after the study. Method of measurement: PMS diagnostic criteria based on DSM-V.
- Secondary Outcome Measures
Name Time Method Physical and mental symptoms. Timepoint: 0 start of study and 1 month, 2 months and 3 months later. Method of measurement: DSM-V.